Polku Therapeutics
PrivateLast Round
Grant
Jan 31, 2025
Total Funding Raised
$2.56M
Company Overview
Polku Therapeutics is a biotechnology company that develops first-in-class small-molecule therapies targeting the PREP–PP2A pathway to treat neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, and frontotemporal dementia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polku Therapeutics Comparables
Compare Polku Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeurOdys Therapeutics | 84% | |
| Treventis Corporation | 78% | |
| Asceneuron | 77% |
Polku Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 31, 2025 | ||||
| Pre Seed | Sep 17, 2024 |
Polku Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovestor | Pre Seed |
| Rainwater Charitable Foundation | Grant |
| Helsinki University Funds | Pre Seed |
| Business Finland | Pre Seed |
| Torrey Pines Investment LLC | Pre Seed |
| Alzheimer's Association | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 31, 2025
$330K from Rainwater Charitable Foundation and Alzheimer's Association.
- Sep 17, 2024
$2.34M round led by Torrey Pines Investment and Innovestor.
Polku Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Polku Therapeutics's valuation, stock price, and market status.
Is Polku Therapeutics a public or private company?
Polku Therapeutics is a private company.
What is the current stock price of Polku Therapeutics?
Polku Therapeutics is a private company, so its shares have no public market price. Caplight tracks Polku Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Polku Therapeutics worth (valuation)?
Valuation information for Polku Therapeutics is not publicly available.
Can I buy Polku Therapeutics stock?
Polku Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Polku Therapeutics's last funding round?
Polku Therapeutics's most recent funding round was Grant on January 31, 2025.
Who are the main investors in Polku Therapeutics?
Key investors in Polku Therapeutics include Innovestor, Torrey Pines Investment LLC.
Will Polku Therapeutics IPO soon?
No public IPO plans have been announced for Polku Therapeutics.
How can I track Polku Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Polku Therapeutics's shares on secondary markets.